首页> 外文期刊>Veterinary Microbiology >Oral administration of Salmonella enterica serovar Typhimurium expressing swine interleukin-18 induces Th1-biased protective immunity against inactivated vaccine of pseudorabies virus.
【24h】

Oral administration of Salmonella enterica serovar Typhimurium expressing swine interleukin-18 induces Th1-biased protective immunity against inactivated vaccine of pseudorabies virus.

机译:口服表达猪白细胞介素18的沙门氏菌血清型鼠伤寒沙门氏菌可诱导Th1偏向于针对伪狂犬病病毒灭活疫苗的保护性免疫。

获取原文
获取原文并翻译 | 示例
           

摘要

Enhancing and/or modulating innate and adaptive immunity by cytokines appears to be greatly useful to provide effective protective immunity against infectious diseases. However, an effective delivery system for mass administration in livestock industry is needed because of limitations such as cost, labor, time, and protein stability. Here the immunomodulatory functions of swine interleukine-18 (swIL-18), known as IFN- gamma -inducing factor (IGIF), were evaluated in a vaccination model of pseudorabies virus (PrV) using attenuated Salmonella enterica serovar Typhimurium as the oral delivery system. The oral administration of S. enterica serovar Typhimurium expressing swIL-18 prior to vaccination with inactivated PrV vaccine induced enhanced levels of serum PrV-specific IgG and its IgG2 isotype, compared to administration of S. enterica serovar Typhimurium harboring the empty vector. Furthermore, S. enterica serovar Typhimurium expressing swIL-18 mounted Th1-biased cellular immune responses against PrV antigen, as evaluated by the production of IFN- gamma and IL-4 from peripheral blood mononuclear cells of piglets. Subsequently, Th1-biased immunity induced by S. enterica serovar Typhimurium expressing swIL-18 showed rapid response and rendered piglets displayed more alleviated clinical signs following the virulent PrV challenge. Also, this alleviation of clinical signs was further confirmed by the reduction of nasal excretion of PrV after challenge. The present study demonstrates the extended use of immunomodulatory functions of swIL-18 orally delivered by attenuated S. enterica serovar Typhimurium.
机译:通过细胞因子增强和/或调节先天性和适应性免疫似乎对提供有效的针对传染病的保护性免疫非常有用。然而,由于诸如成本,人工,时间和蛋白质稳定性的限制,需要用于畜牧业中大规模管理的有效递送系统。在此,在猪伪狂犬病病毒(PrV)疫苗接种模型中,使用减毒的沙门氏菌沙门氏菌评估了猪白细胞介素18(swIL-18)的免疫调节功能,即IFN-γ诱导因子(IGIF)。鼠伤寒血清作为口服递送系统。口服给药。与施用 S相比,在用灭活的PrV疫苗接种疫苗前表达swIL-18的肠型血清型鼠伤寒沙门氏菌可诱导血清PrV特异性IgG及其IgG2同种型水平提高。携带空载体的鼠伤寒鼠伤寒沙门氏菌。此外, S。表达swIL-18的肠型血清鼠伤寒沙门氏菌偏向Th1的针对PrV抗原的细胞免疫反应,通过从仔猪外周血单核细胞产生IFN-γ和IL-4进行评估。随后,由i诱导的Th1偏向免疫。表达swIL-18的肠炎血清型鼠伤寒沙门氏菌显示出快速反应,而致使仔猪在强毒性PrV攻击后显示出更多减轻的临床体征。同样,通过减轻攻击后PrV的鼻腔排泄,进一步证实了这种临床症状的减轻。本研究证明了减毒S口服递送的swIL-18免疫调节功能的广泛应用。肠炎鼠伤寒杆菌。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号